Top Markets
#1 Akedo Akedo +69.97%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.06%
#4 Cross Cross +36.90%
#5 Velvet Velvet +31.95%
#6 Black Phoenix Black Phoenix +26.64%
#7 Cap Cap +22.61%
#8 OVERTAKE OVERTAKE +19.97%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.79%
#10 Ontology Gas Ontology Gas +11.65%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Clasificación en acciones #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Precio por acción
$0.02243487
Última sincronización: 2025-06-04
Capitalización bursátil
$650.09K
Cambio (1 día)
0.39%
Cambio (1 año)
0.00%
País
SE
Comercio Lipidor AB (publ) (LIPI)

Categoría

Healthcare
Ratio P/S de Lipidor AB (publ) (LIPI)
Ratio P/S al August 2026 TTM: 12.49K
Según los informes financieros más recientes y el precio de las acciones de Lipidor AB (publ), el ratio P/S actual (TTM) es 12.49K. Al final de 2023, el ratio P/S era 187.24.
Historial del ratio P/S de Lipidor AB (publ) desde 2016 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 12.49K 89.82%
2024 6.58K 3,414.61%
2023 187.24 -60.49%
2022 473.93 2,985.50%
2021 15.36 -97.13%
2020 534.79 -88.42%
2019 4.62K 822.07%
2018 501.03 35.80%
2017 368.94 -14.60%
2016 432.02 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
14.97 -99.88%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.31 -99.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.06 -99.94%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -99.96%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.90 -99.96%
US